Evidence map›Paper›PMID 29458422›Full record

ArticleMicrobiome2018

The antibiotic resistome and microbiota landscape of refugees from Syria, Iraq and Afghanistan in Germany.

Robert Häsler, Christian Kautz, Ateequr Rehman, Rainer Podschun, Volker Gassling, Pius Brzoska, Jon Sherlock, Jan-Thorsten Gräsner, Gesine Hoppenstedt, Sabine Schubert and 13 more

Open access · goldAbstract read
In one paragraph

Article in Microbiome, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Stressor-Specific Microbiota Intervention.Frontiers in nutrition · 2022
    Article
  8. Article
  9. Article
  10. NOD2 Influences Trajectories of Intestinal Microbiota Recovery After Antibiotic Perturbation.Cellular and molecular gastroenterology and hepatology · 2020
    Article
  11. THE EXPOSOME IN HUMAN EVOLUTION: FROM DUST TO DIESEL.The Quarterly review of biology · 2019
    Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 2 countries.

Robert HäslerInstitute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Christian Albrecht University of Kiel, Campus Kiel, Rosalind-Franklin-Straße 12, 24105, Kiel, Germany.
Christian KautzPharmaceutical Institute, Department of Clinical Pharmacy, Christian Albrecht University of Kiel, Kiel, Germany.
Ateequr RehmanInstitute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Christian Albrecht University of Kiel, Campus Kiel, Rosalind-Franklin-Straße 12, 24105, Kiel, Germany.
Rainer PodschunInstitute of Infection Medicine, Christian Albrecht University of Kiel, Kiel, Germany.
Volker GasslingDepartment of Oral and Maxillofacial Surgery, University Hospital of Schleswig-Holstein, Kiel, Germany.
Pius BrzoskaThermo Fisher Scientific, San Francisco, CA, USA.
Jon SherlockThermo Fisher Scientific, San Francisco, CA, USA.
Jan-Thorsten GräsnerDepartment of Anaesthesia and Intensive Care Medicine, University Hospital of Schleswig-Holstein, Kiel, Germany.
Gesine HoppenstedtInstitute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Christian Albrecht University of Kiel, Campus Kiel, Rosalind-Franklin-Straße 12, 24105, Kiel, Germany.
Sabine SchubertInstitute of Infection Medicine, Christian Albrecht University of Kiel, Kiel, Germany.
Astrid FerlinzThermo Fisher Scientific, Life Technologies GmbH, Darmstadt, Germany.
Wolfgang LiebPOPGEN Biobank and Institute of Epidemiology, Christian Albrecht University of Kiel, Kiel, Germany.
Matthias LaudesPOPGEN Biobank and Institute of Epidemiology, Christian Albrecht University of Kiel, Kiel, Germany.
Femke-Anouska HeinsenInstitute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Christian Albrecht University of Kiel, Campus Kiel, Rosalind-Franklin-Straße 12, 24105, Kiel, Germany.
Jens ScholzDepartment of Anaesthesia and Intensive Care Medicine, University Hospital of Schleswig-Holstein, Kiel, Germany.
Dag HarmsenDepartment of Periodontology and Restorative Dentistry, University Hospital Münster, Münster, Germany.
Andre FrankeInstitute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Christian Albrecht University of Kiel, Campus Kiel, Rosalind-Franklin-Straße 12, 24105, Kiel, Germany.
Swantje EisendDepartment of Internal Medicine, University Hospital of Schleswig-Holstein, Campus Kiel, Rosalind-Franklin-Straße 12, 24105, Kiel, Germany.
Thomas KunzePharmaceutical Institute, Department of Clinical Pharmacy, Christian Albrecht University of Kiel, Kiel, Germany.
Helmut FickenscherInstitute of Infection Medicine, Christian Albrecht University of Kiel, Kiel, Germany.
Stephan OttDepartment of Internal Medicine, University Hospital of Schleswig-Holstein, Campus Kiel, Rosalind-Franklin-Straße 12, 24105, Kiel, Germany.
Philip RosenstielInstitute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Christian Albrecht University of Kiel, Campus Kiel, Rosalind-Franklin-Straße 12, 24105, Kiel, Germany. p.rosenstiel@mucosa.de.
Stefan SchreiberInstitute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Christian Albrecht University of Kiel, Campus Kiel, Rosalind-Franklin-Straße 12, 24105, Kiel, Germany. s.schreiber@mucosa.de.
Kiel University · DEUniversity of Lübeck · DEUniversity Hospital Schleswig-Holstein · DEThermo Fisher Scientific (United States) · USThermo Fisher Scientific (Germany) · DEUniversity Hospital Münster · DE

Funding

Bundesministerium für Forschung und Technologie SysINFLAME CP3/4Deutsche Forschungsgemeinschaft CRC1182 C2Deutsche Forschungsgemeinschaft EXC306
6 · The paper itself

Abstract

backgroundMultidrug-resistant bacteria represent a substantial global burden for human health, potentially fuelled by migration waves: in 2015, 476,649 refugees applied for asylum in Germany mostly as a result of the Syrian crisis. In Arabic countries, multiresistant bacteria cause significant problems for healthcare systems. Currently, no data exist describing antibiotic resistances in healthy refugees. Here, we assess the microbial landscape and presence of antibiotic resistance genes (ARGs) in refugees and German controls. To achieve this, a systematic study was conducted in 500 consecutive refugees, mainly from Syria, Iraq, and Afghanistan and 100 German controls. Stool samples were subjected to PCR-based quantification of 42 most relevant ARGs, 16S ribosomal RNA gene sequencing-based microbiota analysis, and culture-based validation of multidrug-resistant microorganisms.

resultsThe fecal microbiota of refugees is substantially different from that of resident Germans. Three categories of resistance profiles were found: (i) ARGs independent of geographic origin of individuals comprising BIL/LAT/CMA, ErmB, and mefE; (ii) vanB with a high prevalence in Germany; and (iii) ARGs showing substantially increased prevalences in refugees comprising CTX-M group 1, SHV, vanC1, OXA-1, and QnrB. The majority of refugees carried five or more ARGs while the majority of German controls carried three or less ARGs, although the observed ARGs occurred independent of signatures of potential pathogens.

conclusionsOur results, for the first time, assess antibiotic resistance genes in refugees and demonstrate a substantially increased prevalence for most resistances compared to German controls. The antibiotic resistome in refugees may thus require particular attention in the healthcare system of host countries.

Indexed as

BacteriaAfghanistanDrug Resistance, Multiple, BacterialFecesGermanyHumansIraqMicrobiotaRefugeesRNA, Ribosomal, 16SSyriaRNA, Ribosomal, 16SAntibiotic resistanceHumanRefugeesResistome

Identifiers

PMID29458422
PMCPMC5819293
OpenAlexW2789169916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.